logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Thomas W. Flaig

Department of Medicine

53H-index
391Paper Count
2.3WCitation Count
Published Papers 72
Publication Date
logo
Integrating clinically actionable biomarkers into bladder cancer care — recommendations from the International Bladder Cancer Group
errNature Reviews Urology
IF14.6
err2026-08-05
err0
PREAI
errPatrick J. Hensley; Jeremy Y. C. Teoh; Roger Li; Shilpa Gupta; Laura Bukavina; Kent W. Mouw; Niyati Lobo; Brigida Anna Maiorano; Wei Shen Tan; Piyush Agarwal; Hikmat A. Al-Ahmadie; Trinity J. Bivalacqua; Liang Cheng; Thomas W. Flaig; Charles C. Guo; Amir Horowitz; Wassim Kassouf; Max R. Kates; Badrinath R. Konety; Janet B. Kukreja; Yair Lotan; David J. McConkey; Laura S. Mertens; Maria Carmen Mir; Marco Moschini; Andrea Necchi; Karima Oualla; Vignesh T. Packiam; Bogdana Schmidt; Roger J. Buckley; Ashish M. Kamat
errShare
errSave
EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma
errESMO Open
IF8.3
err2026-05-19
err0
errOAAI
errJ.E. Rosenberg; P.H. O'Donnell; D.P. Petrylak; T.W. Flaig; C.J. Hoimes; S. Gupta; N. Mar; T.W. Friedlander; S.T. Tagawa; M.A. Bilen; J.R. Brown; R.R. McKay; J.R. Merchan; S. Srinivas; S. Gorla; B.H. Moreno; G. Davis; H.S. Wirtz; Y. Zhu; M.I. Milowsky
errShare
errSave
Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium
errcurrent oncology reports
IF3.4
err2025-05-14
err0
errOAAI
errFahey, Catherine C.; Clark-Garvey, Sean; Porten, Sima; Kamat, Ashish M.; Flaig, Thomas W.; Taylor, John A.; Kim, William Y.; Milowsky, Matthew I.
errShare
errSave
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group
errEuropean Urology
IF25.2
err2025-04-22
err0
PREAI
errShilpa Gupta; Patrick J. Hensley; Roger Li; Ananya Choudhury; Siamak Daneshmand; Bishoy M. Faltas; Thomas W. Flaig; G. Daniel Grass; Petros Grivas; Donna E. Hansel; Comron Hassanzadeh; Wassim Kassouf; Janet Kukreja; Arturo Mendoza-Valdés; Marco Moschini; Kent W. Mouw; Neema Navai; Andrea Necchi; Jonathan E. Rosenberg; Jeffrey S. Ross
errShare
errSave
Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study
errSUPPORTIVE CARE IN CANCER
IF3
err2025-04-08
err0
PREAI
errJones, Michael K.; Nicklawsky, Andrew; Shortt, Jonathan; Pattee, Jack; Kennerley, Victoria; Eule, Corbin J.; Candelario, Nellowe; O'Donnell, Peter H.; Flaig, Thomas W.
errShare
errSave
Cardiovascular Safety in Oncology Clinical Trials JACC: CardioOncology Primer
errJACC: CARDIOONCOLOGY
IF12.8
err2025-02-01
err1
errOAAI
errBonaca, Marc P.; Lang, Ninian N.; Chen, Alice; Amiri-Kordestani, Laleh; Lipka, Leslie; Zwiewka, Michal; Strnadova, Colette; Klaar, Sigrid; Dent, Susan; Janicijevic, Tijana Krnjeta; Herrmann, Joerg; Barac, Ana; Boer, Rudolf A. de; Deswal, Anita; Schou, Morten; Neilan, Tomas G.; van der Meer, Peter; Moslehi, Javid; Kondapalli, Lavanya; Ky, Bonnie; Fernandez, Teresa Lopez; Cornell, R. Frank; Flaig, Thomas W.; Hsia, Judith; Sharon, Elad; de Azambuja, Evandro; Seltzer, Jonathan; Januzzi, James L.; Petrie, Mark C.
errShare
errSave
Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database
errPROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
err2024-11-21
err0
PREAI
errEule, Corbin J.; Warren, Adam; Kuna, Elizabeth Molina; Robin, Tyler P.; Gershman, Boris; Kim, Simon P.; Flaig, Thomas W.
errShare
errSave
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial
errEUROPEAN UROLOGY
IF25.2
err2024-10-01
err1
PREAI
errPlimack, Elizabeth R.; Tangen, Catherine; Plets, Melissa; Kokate, Rutika; Xiu, Joanne; Nabhan, Chadi; Ross, Eric A.; Grundy, Erin; Choi, Woonyoung; Dinney, Colin P. N.; Lee, I. -Ling C.; Fong, Megan; Lucia, M. Scott; Daneshmand, Siamak; Theodorescu, Dan; Goldkorn, Amir; Lerner, Seth P.; Flaig, Thomas W.; McConkey, David J.
errShare
errSave
Novel biomarker, ephrinB2 (B2), predicts resistance to treatment and poor overall survival (OS) metastatic urothelial carcinoma (mUC)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errSadeghi, S.; Mar, N.; Tsao-Wei, D.; Siddiqi, I.; Freeman, D.; Torkko, K.; van Bokhoven, A.; Flaig, T.; Gill, P.; Kalebasty, A. Rezazadeh; Sonpavde, G. P.; Bellmunt, J.
errShare
errSave
Study EV-103 dose escalation/cohort A (DE/A): 5y follow-up of first-line (1L) enfortumab vedotin (EV) plus pembrolizumab (P) in cisplatin (CIS)-ineligible locally advanced or metastatic urothelial carcinoma (la/mUC)
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err2
PREAI
errRosenberg, J. E.; Petrylak, D. P.; Flaig, T.; Hoimes, C. J.; Gupta, S.; O'Donnell, P. H.; Mar, N.; Friedlander, T.; Tagawa, S. T.; Bilen, M. A.; Brown, J. R.; McKay, R. R.; Merchan, J. R.; Srinivas, S.; Shetty, A.; Homet Moreno, B.; Davis, G.; Wirtz, H.; Zhu, Y.; Milowsky, M. I.
errShare
errSave
Updates in the Treatment of Metastatic Urothelial Cancer
errJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
err2024-05-01
err0
errOAAI
errFlaig, Thomas W.
errShare
errSave
Bladder Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines
errJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
err2024-05-01
err13
errOAAI
errFlaig, Thomas W.; Spiess, Philippe E.; Abern, Michael; Agarwal, Neeraj; Bangs, Rick; Buyyounouski, Mark K.; Chan, Kevin; Chang, Sam S.; Chang, Paul; Friedlander, Terence; Greenberg, Richard E.; Guru, Khurshid A.; Herr, Harry W.; Hoffman-Censits, Jean; Kaimakliotis, Hristos; Kishan, Amar U.; Kundu, Shilajit; Lele, Subodh M.; Mamtani, Ronac; Mian, Omar Y.; Michalski, Jeff; Montgomery, Jeffrey S.; Parikh, Mamta; Patterson, Anthony; Peyton, Charles; Plimack, Elizabeth R.; Preston, Mark A.; Richards, Kyle; Sexton, Wade J.; Siefker-Radtke, Arlene O.; Stewart, Tyler; Sundi, Debasish; Tollefson, Matthew; Tward, Jonathan; Wright, Jonathan L.; Cassara, Carly J.; Gurski, Lisa A.
errShare
errSave
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab
errFUTURE ONCOLOGY
IF2.6
err2023-11-23
err0
errOAAI
errHoimes, Christopher J.; Flaig, Thomas W.; Milowsky, Matthew, I; Friedlander, Terence W.; Bilen, Mehmet Asim; Gupta, Shilpa; Srinivas, Sandy; Merchan, Jaime R.; Mckay, Rana R.; Petrylak, Daniel P.; Sasse, Carolyn; Moreno, Blanca Homet; Yu, Yao; Carret, Anne-Sophie; Rosenberg, Jonathan E.
errShare
errSave
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2023-10-01
err16
PREAI
errLu, Yi-Tsung; Plets, Melissa; Morrison, Gareth; Cunha, Alexander T.; Cen, Steven Y.; Rhie, Suhn K.; Siegmund, Kimberly D.; Daneshmand, Siamak; Quinn, David I.; Meeks, Joshua J.; Lerner, Seth P.; Petrylak, Daniel P.; Mcconkey, David; Flaig, Thomas W.; Thompson Jr, Ian M.; Goldkorn, Amir
errShare
errSave
Study EV-103 cohort L: Perioperative treatment w/ enfortumab vedotin (EV) monotherapy in cisplatin (cis)ineligible patients (pts) w/ muscle invasive bladder cancer (MIBC)
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err5
errOAAI
errSridhar, S.; O'Donnell, P. H.; Flaig, T. W.; Rosenberg, J. E.; Hoimes, C. J.; Milowsky, M. I.; Srinivas, S.; George, S.; McKay, R. R.; Petrylak, D. P.; Barata, P. M. Coelho; Hwang, C.; Cruz-Correa, M.; Iafolla, M.; Mckean, M.; Dreicer, R.; Brancato, S.; Lukas, J. J.; Yu, Y.; Moon, H.
errShare
errSave
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314 NCT02177695) ;
errEUROPEAN UROLOGY
IF25.2
err2023-09-01
err3
errOAAI
errFlaig, Thomas W.; Tangen, Catherine M.; Daneshmand, Siamak; Alva, Ajjai Shivaram; Lucia, M. Scott; McConkey, David James; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I.; Bangs, Rick; MacVicar, Gary R.; Bastos, Bruno R.; Fowles, Jared S.; Gustafson, Daniel L.; Plets, Melissa; Thompson Jr, Ian M.; Lerner, Seth P.
errShare
errSave
Burden of Cardiovascular Disease in Immune Checkpoint Inhibitor-Treated Patients Reconciling Adjudicated and Coded Outcomes
errJACC: CARDIOONCOLOGY
IF12.8
err2022-12-01
err6
errOAAI
errKondapalli, Lavanya; Hsia, Judith; Miller, Ronni; Flaig, Thomas W.; Bonaca, Marc P.
errShare
errSave
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations
errPROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
err2022-11-19
err2
PREAI
errEule, Corbin J.; Flaig, Thomas W.; Wong, Katy; Graf, Ryon; Lam, Elaine T.
errShare
errSave
Bladder Cancer, Version 2.2022 Featured Updates to the NCCN Guidelines
errJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
err2022-08-01
err171
errOAAI
errFlaig, Thomas W.; Spiess, Philippe E.; Abern, Michael; Agarwal, Neeraj; Bangs, Rick; Boorjian, Stephen A.; Buyyounouski, Mark K.; Chan, Kevin; Chang, Sam; Friedlander, Terence; Greenberg, Richard E.; Guru, Khurshid A.; Herr, Harry W.; Hoffman-Censits, Jean; Kishan, Amar; Kundu, Shilajit; Lele, Subodh M.; Mamtani, Ronac; Margulis, Vitaly; Mian, Omar Y.; Michalski, Jeff; Montgomery, Jeffrey S.; Nandagopal, Lakshminarayanan; Pagliaro, Lance C.; Parikh, Mamta; Patterson, Anthony; Plimack, Elizabeth R.; Pohar, Kamal S.; Preston, Mark A.; Richards, Kyle; Sexton, Wade J.; Siefker-Radtke, Arlene O.; Tollefson, Matthew; Tward, Jonathan; Wright, Jonathan L.; Dwyer, Mary A.; Cassara, Carly J.; Gurski, Lisa A.
errShare
errSave
Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis
errFRONTIERS IN ONCOLOGY
IF3.3
err2022-06-29
err5
errOAAI
errBourlon, Maria T.; Verduzco-Aguirre, Haydee; Molina, Elizabeth; Meyer, Elisabeth; Kessler, Elizabeth; Kim, Simon P.; Spiess, Philippe E.; Flaig, Thomas
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
R
Robert J. Motzer
H-index: 148 · Papers: 1.6K
J
James L. Januzzi
H-index: 134 · Papers: 1.2K
R
Rudolf A. de Boer
H-index: 129 · Papers: 1.0K
View more